Drug Sponsors

Elan announces spin-off of discovery science with Neotope Biosciences

Monday, August 13, 2012 11:50 AM

The board of directors of Elan, an Irish neuroscience-focused biotech, has approved the spin-off of discovery science with the separation of Neotope Biosciences from Elan.

More... »

Pluristem, Cato Research collaborate on intermittent claudication

Monday, August 13, 2012 11:32 AM

Pluristem Therapeutics, a developer of placenta-based cell therapies based in Israel, has selected Cato Research as its CRO for the German portion of the company's phase II trial in intermittent claudication (IC) under the auspices of the Paul-Ehrlich Institute (PEI).

More... »

ADi awarded $2.5M SBIR grant to identify malaria protection biomarkers

Monday, August 13, 2012 10:13 AM

Antigen Discovery (ADi), a biotech based in Irvine, Calif., has received a phase II Small Business Innovation and Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

More... »

Sun Pharmaceutical to acquire Taro

Monday, August 13, 2012 09:57 AM

Sun Pharmaceutical Industries, an Indian specialty pharmaceutical company, and Taro Pharmaceutical Industries, a multinational pharmaceutical company, have entered into a merger agreement together with certain affiliates of Sun Pharma.

More... »

Intercept Pharmaceuticals closes $30M Series C financing

Friday, August 10, 2012 03:15 PM

Intercept Pharmaceuticals, a New York-based clinical stage biopharmaceutical company focused on chronic liver diseases, has completed a $30 million Series C preferred stock financing led by OrbiMed Advisors, a global healthcare investment firm, with existing majority investor Genextra of Italy also participating.

More... »

DOD awards Luminex $11.6M to develop biothreat detection tech

Friday, August 10, 2012 02:42 PM

Luminex, a developer and manufacturer of biological testing technologies based in Austin, Texas, has been awarded a contract worth up to $11.6 million over three and a half years by the Department of Defense (DOD).

More... »

Aquavit, Green Cross sign strategic collaboration MOU on IBX-001

Friday, August 10, 2012 12:07 PM

Aquavit Pharmaceuticals, a multi-specialty healthcare company of New York, and Green Cross, a South Korean biotechnology company, signed a Memorandum of Understanding (MOU) towards establishing their strategic collaboration surrounding the development and commercialization of Aquavit's IBX-001 in Asia.

More... »

Platinum-Montaur finances $20M to Echo Therapeutics

Friday, August 10, 2012 11:29 AM

Platinum-Montaur Life Sciences has agreed to provide Echo Therapeutics, a transdermal medical device company, a credit facility of up to $20 million.

More... »

Accu-Break, Alembic enter into product development and license agreement

Friday, August 10, 2012 11:02 AM

India-based Accu-Break Pharmaceuticals (ABP) has entered into a development and license agreement with Alembic Pharmaceuticals of Plantation, Fla., to develop new brand products that will use ABP’s innovative Accu-Break tablet technologies.

More... »

Nodality, Pfizer form multi-year collaboration on autoimmune disease

Thursday, August 9, 2012 02:16 PM

Nodality, a San Francisco-based personalized medicine biotech, has formed a strategic collaboration to provide proprietary single cell network profiling (SCNP) technology as a tool for the development of Pfizer compounds.

More... »